JBPOS0101 regulates amyloid beta, tau, and glial cells in an Alzheimer's disease model.
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease characterized by cognitive dysfunction and memory loss as the main symptoms. The deposition of amyloid beta (Aβ) and tau hyperphosphorylation are hallmarks of AD and are major therapeutic targets. However, the exact etiolo...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Public Library of Science (PLoS)
2020-01-01
|
| Colección: | PLoS ONE |
| Acceso en línea: | https://doi.org/10.1371/journal.pone.0237153 |